
NATURE . COM {
}
Title:
Reversibility and recurrence of IGF-IR-induced mammary tumors | Oncogene
Description:
The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Education
- Health & Fitness
- Science
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.
Keywords {π}
cancer, article, google, scholar, cas, growth, breast, insulinlike, receptor, factor, res, nature, oncogene, mammary, tumor, human, igfir, access, tumors, expression, cell, content, research, cookies, recurrence, jones, campbell, moorehead, transgenic, privacy, function, signaling, mouse, epithelial, transition, open, nat, type, monoclonal, antibody, pubmed, tumorigenesis, moody, ontario, data, petrik, targeting, development, model, transcriptional,
Topics {βοΈ}
nature portfolio permissions reprints privacy policy nature formalin-fixed paraffin-embedded tissues cancer research society tgf-beta-induced collagen expression c-myc-induced mammary adenocarcinomas advertising igf-ir-induced mammary tumors social media health research p19arf/p53 pathway lesions author information authors mammary gland development anti-igf-ir therapies real-time pcr primer conditional wnt-induced tumorigenesis targeting igf-ir author correspondence tumor-size-dependent regression endocrine-responsive breast cancer springerlink instant access personal data recombinant humanized anti-insulin tumor development igf-ir-independent mechanisms signal transduction function regulates epithelial plasticity data protection permissions invasive breast cancers transgenic mouse model igf-ir-dependent e-cadherin gene expression accelerates mammary tumorigenesis breast cancer cells kinase activity human breast cancer igf-ir dependence igf-ir independence human lung tumors igf-ir signaling igf-ir results growth factor receptor breast cancer panagiotis induces tumor formation metastasizing mammary carcinomas igf-ii mrna privacy
Questions {β}
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(127)
- Financial intake of https://link.springer.com/article/10.1038/onc.2009.79?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle
- How much revenue does https://doi.org/10.1038%2Fnrc2256 generate?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Models%2C%20mechanisms%20and%20clinical%20evidence%20for%20cancer%20dormancy&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2256&volume=7&pages=834-846&publication_year=2007&author=Aguirre-Ghiso%2CJA?
- What's the financial outcome of https://doi.org/10.1038%2Fnrc721?
- How much does http://scholar.google.com/scholar_lookup?&title=Endocrine-responsive%20breast%20cancer%20and%20strategies%20for%20combating%20resistance&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc721&volume=2&pages=101-112&publication_year=2002&author=Ali%2CS&author=Coombes%2CRC pull in?
- How much revenue does https://doi.org/10.1172%2FJCI114315 bring in?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20the%20type%20I%20somatomedin%20receptor%20inhibits%20growth%20of%20human%20breast%20cancer%20cells%20in%20athymic%20mice&journal=J%20Clin%20Invest&doi=10.1172%2FJCI114315&volume=84&pages=1418-1423&publication_year=1989&author=Arteaga%2CC&author=Kitten%2CK&author=Coronado%2CE?
- How much income does https://doi.org/10.1038%2Fbjc.1995.484 have?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Mammary%20cancer%20in%20transgenic%20mice%20expressing%20insulin-like%20growth%20factor%20II%20%28IGF-II%29&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1995.484&volume=72&pages=1189-1193&publication_year=1995&author=Bates%2CP&author=Fisher%2CR&author=Ward%2CA&author=Richardson%2CL&author=Hill%2CDJ&author=Graham%2CCF?
- What's the financial outcome of https://doi.org/10.1016%2Fj.ccr.2004.10.013?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Lack%20of%20sustained%20regression%20of%20c-MYC-induced%20mammary%20adenocarcinomas%20following%20brief%20or%20prolonged%20MYC%20inactivation&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2004.10.013&volume=6&pages=577-586&publication_year=2004&author=Boxer%2CRB&author=Jang%2CJW&author=Sintasath%2CL&author=Chodosh%2CLA?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14695208?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20fully%20human%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor%20blocks%20ligand-dependent%20signaling%20and%20inhibits%20human%20tumor%20growth%20in%20vivo&journal=Cancer%20Res&volume=63&pages=8912-8921&publication_year=2003&author=Burtrum%2CD&author=Zhu%2CZ&author=Lu%2CD&author=Anderson%2CDM&author=Prewett%2CM&author=Pereira%2CDS make?
- Learn about the earnings of https://doi.org/10.1158%2F0008-5472.CAN-04-4602
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Tumor%20development%20by%20transgenic%20expression%20of%20a%20constitutively%20active%20insulin-like%20growth%20factor%20I%20receptor&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-4602&volume=65&pages=3781-3787&publication_year=2005&author=Carboni%2CJM&author=Lee%2CAV&author=Hadsell%2CDL&author=Rowley%2CBR&author=Lee%2CFY&author=Bol%2CDK have monthly?
- Explore the financials of https://doi.org/10.1158%2F0008-5472.CAN-06-2044
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Mesenchymal-to-epithelial%20transition%20facilitates%20bladder%20cancer%20metastasis%3A%20role%20of%20fibroblast%20growth%20factor%20receptor-2&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2044&volume=66&pages=11271-11278&publication_year=2006&author=Chaffer%2CCL&author=Brennan%2CJP&author=Slavin%2CJL&author=Blick%2CT&author=Thompson%2CEW&author=Williams%2CED?
- Monthly income for https://doi.org/10.1038%2Fsj.cgt.7700126
- See how much http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20human%20breast%20cancer%20cells%20with%20antisense%20RNA%20to%20the%20type%20I%20insulin-like%20growth%20factor%20receptor%20inhibits%20cell%20growth%2C%20suppresses%20tumorigenesis%2C%20alters%20the%20metastatic%20potential%2C%20and%20prolongs%20survival%20in%20vivo&journal=Cancer%20Gene%20Ther&doi=10.1038%2Fsj.cgt.7700126&volume=7&pages=384-395&publication_year=2000&author=Chernicky%2CCL&author=Yi%2CL&author=Tan%2CH&author=Gan%2CSU&author=Ilan%2CJ makes per month
- Profit of https://doi.org/10.1038%2F84691
- What's http://scholar.google.com/scholar_lookup?&title=c-MYC%20induces%20mammary%20tumorigenesis%20by%20means%20of%20a%20preferred%20pathway%20involving%20spontaneous%20Kras2%20mutations&journal=Nat%20Med&doi=10.1038%2F84691&volume=7&pages=235-239&publication_year=2001&author=D%E2%80%99Cruz%2CCM&author=Gunther%2CEJ&author=Boxer%2CRB&author=Hartman%2CJL&author=Sintasath%2CL&author=Moody%2CSE's gross income?
- How much revenue does https://doi.org/10.1172%2FJCI33320 generate?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Tumor%20escape%20in%20a%20Wnt1-dependent%20mouse%20breast%20cancer%20model%20is%20enabled%20by%20p19Arf%2Fp53%20pathway%20lesions%20but%20not%20p16%20Ink4a%20loss&journal=J%20Clin%20Invest&doi=10.1172%2FJCI33320&volume=118&pages=51-63&publication_year=2008&author=Debies%2CMT&author=Gestl%2CSA&author=Mathers%2CJL&author=Mikse%2COR&author=Leonard%2CTL&author=Moody%2CSE?
- What's the income generated by https://link.springer.com/doi/10.1007/s10549-006-9168-1 each month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=The%20growth%20hormone%20receptor%20antagonist%20pegvisomant%20blocks%20both%20mammary%20gland%20development%20and%20MCF-7%20breast%20cancer%20xenograft%20growth&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-006-9168-1&volume=98&pages=315-327&publication_year=2006&author=Divisova%2CJ&author=Kuiatse%2CI&author=Lazard%2CZ&author=Weiss%2CH&author=Vreeland%2CF&author=Hadsell%2CDL?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9699666 earn?
- How much income is http://scholar.google.com/scholar_lookup?&title=A%20dominant%20negative%20mutant%20of%20the%20insulin-like%20growth%20factor-I%20receptor%20inhibits%20the%20adhesion%2C%20invasion%20and%20metastasis%20of%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=3353-3361&publication_year=1998&author=Dunn%2CSE&author=Ehrlich%2CM&author=Sharp%2CNJ&author=Keiss%2CK&author=Solomon%2CG&author=Hawkins%2CR earning monthly?
- Income figures for https://doi.org/10.1038%2Fsj.onc.1208429
- What's http://scholar.google.com/scholar_lookup?&title=DeltaEF1%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20and%20regulates%20epithelial%20plasticity%20in%20breast%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1208429&volume=24&pages=2375-2385&publication_year=2005&author=Eger%2CA&author=Aigner%2CK&author=Sonderegger%2CS&author=Dampier%2CB&author=Oehler%2CS&author=Schreiber%2CM's gross income?
- How much income does https://doi.org/10.1158%2F1535-7163.MCT-05-0252 have?
- How much income is http://scholar.google.com/scholar_lookup?&title=Novel%20human%20monoclonal%20antibodies%20to%20insulin-like%20growth%20factor%20%28IGF%29-II%20that%20potently%20inhibit%20the%20IGF%20receptor%20type%20I%20signal%20transduction%20function&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-05-0252&volume=5&pages=114-120&publication_year=2006&author=Feng%2CY&author=Zhu%2CZ&author=Xiao%2CX&author=Choudhry%2CV&author=Barrett%2CJC&author=Dimitrov%2CDS earning monthly?
- How much cash flow does https://link.springer.com/doi/10.1007/BF01807035 have monthly?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=IGF-II%20mRNA%20and%20protein%20are%20expressed%20in%20the%20stroma%20of%20invasive%20breast%20cancers%3A%20an%20in%20situ%20hybridization%20and%20immunohistochemistry%20study&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01807035&volume=41&pages=43-50&publication_year=1996&author=Giani%2CC&author=Cullen%2CKJ&author=Campani%2CD&author=Rasmussen%2CA
- How much does https://doi.org/10.1002%2Fijc.20543 rake in every month?
- What's http://scholar.google.com/scholar_lookup?&title=A%20recombinant%20humanized%20anti-insulin-like%20growth%20factor%20receptor%20type%20I%20antibody%20%28h7C10%29%20enhances%20the%20antitumor%20activity%20of%20vinorelbine%20and%20anti-epidermal%20growth%20factor%20receptor%20therapy%20against%20human%20cancer%20xenografts&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20543&volume=113&pages=316-328&publication_year=2005&author=Goetsch%2CL&author=Gonzalez%2CA&author=Leger%2CO&author=Beck%2CA&author=Pauwels%2CPJ&author=Haeuw%2CJF's gross income?
- How much profit is https://doi.org/10.1101%2Fgad.1051603 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Impact%20of%20p53%20loss%20on%20reversal%20and%20recurrence%20of%20conditional%20Wnt-induced%20tumorigenesis&journal=Genes%20Dev&doi=10.1101%2Fgad.1051603&volume=17&pages=488-501&publication_year=2003&author=Gunther%2CEJ&author=Moody%2CSE&author=Belka%2CGK&author=Hahn%2CKT&author=Innocent%2CN&author=Dugan%2CKD pull in monthly?
- Find out how much https://doi.org/10.1038%2Fsj.onc.1203386 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=Cooperative%20interaction%20between%20mutant%20p53%20and%20des%281-3%29IGF-I%20accelerates%20mammary%20tumorigenesis&journal=Oncogene&doi=10.1038%2Fsj.onc.1203386&volume=19&pages=889-898&publication_year=2000&author=Hadsell%2CDL&author=Murphy%2CKL&author=Bonnette%2CSG&author=Reece%2CN&author=Laucirica%2CR&author=Rosen%2CJM net monthly?
- What's the income of https://doi.org/10.1158%2F1078-0432.CCR-07-1118?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Phase%20I%20dose%20escalation%20study%20of%20the%20anti%20insulin-like%20growth%20factor-I%20receptor%20monoclonal%20antibody%20CP-751%2C871%20in%20patients%20with%20refractory%20solid%20tumors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1118&volume=13&pages=5834-5840&publication_year=2007&author=Haluska%2CP&author=Shaw%2CHM&author=Batzel%2CGN&author=Yin%2CD&author=Molina%2CJR&author=Molife%2CLR
- How much revenue does https://doi.org/10.1016%2FS0140-6736%2897%2910384-1 generate?
- Get to know http://scholar.google.com/scholar_lookup?&title=Circulating%20concentrations%20of%20insulin-like%20growth%20factor-I%20and%20risk%20of%20breast%20cancer&journal=Lancet&doi=10.1016%2FS0140-6736%2897%2910384-1&volume=351&pages=1393-1396&publication_year=1998&author=Hankinson%2CSE&author=Willett%2CWC&author=Colditz%2CGA&author=Hunter%2CDJ&author=Michaud%2CDS&author=Deroo%2CB's earnings
- What's the financial intake of https://doi.org/10.1056%2FNEJMra043186?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%E2%80%94mechanism%20of%20action%20and%20use%20in%20clinical%20practice&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMra043186&volume=357&pages=39-51&publication_year=2007&author=Hudis%2CCA
- What's the income generated by https://doi.org/10.1002%2Fjcp.21223 each month?
- What's http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20and%20mesenchymal-epithelial%20transitions%20in%20carcinoma%20progression&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.21223&volume=213&pages=374-383&publication_year=2007&author=Hugo%2CH&author=Ackland%2CML&author=Blick%2CT&author=Lawrence%2CMG&author=Clements%2CJA&author=Williams%2CED's gross income?
- Profit of https://doi.org/10.1038%2Fsj.onc.1209955
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Transgenic%20overexpression%20of%20IGF-IR%20disrupts%20mammary%20ductal%20morphogenesis%20and%20induces%20tumor%20formation&journal=Oncogene&doi=10.1038%2Fsj.onc.1209955&volume=26&pages=1636-1644&publication_year=2007&author=Jones%2CRA&author=Campbell%2CCI&author=Gunther%2CEJ&author=Chodosh%2CLA&author=Petrik%2CJJ&author=Khokha%2CR?
- https://doi.org/10.1158%2F1541-7786.MCR-07-2157's total income per month
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20a%20novel%20primary%20mammary%20tumor%20cell%20line%20reveals%20that%20cyclin%20D1%20is%20regulated%20by%20the%20type%20I%20insulin-like%20growth%20factor%20receptor&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-07-2157&volume=6&pages=819-828&publication_year=2008&author=Jones%2CRA&author=Campbell%2CCI&author=Petrik%2CJJ&author=Moorehead%2CRA bring in?
- Monthly income for https://doi.org/10.1073%2Fpnas.0611192104
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=MicroRNA-192%20in%20diabetic%20kidney%20glomeruli%20and%20its%20function%20in%20TGF-beta-induced%20collagen%20expression%20via%20inhibition%20of%20E-box%20repressors&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0611192104&volume=104&pages=3432-3437&publication_year=2007&author=Kato%2CM&author=Zhang%2CJ&author=Wang%2CM&author=Lanting%2CL&author=Yuan%2CH&author=Rossi%2CJJ?
- What's the income of https://doi.org/10.2325%2Fjbcs.954?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Current%20clinical%20trials%20of%20endocrine%20therapy%20for%20breast%20cancer&journal=Breast%20Cancer&doi=10.2325%2Fjbcs.954&volume=14&pages=200-214&publication_year=2007&author=Kurebayashi%2CJ?
- How much does https://doi.org/10.1016%2FS0304-3835%2803%2900159-9 gross monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20insulin-like%20growth%20factor%20system%20and%20cancer&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2803%2900159-9&volume=195&pages=127-137&publication_year=2003&author=LeRoith%2CD&author=Roberts%2CCT?
- What's the income of https://doi.org/10.1002%2Fijc.20814?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Use%20of%20a%20transgenic%20mouse%20model%20to%20identify%20markers%20of%20human%20lung%20tumors&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20814&volume=114&pages=977-982&publication_year=2005&author=Linnerth%2CNM&author=Sirbovan%2CK&author=Moorehead%2CRA?
- How much does https://doi.org/10.1093%2Fjnci%2F93.24.1852 pull in monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-I%20receptor%20signaling%20and%20resistance%20to%20trastuzumab%20%28Herceptin%29&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F93.24.1852&volume=93&pages=1852-1857&publication_year=2001&author=Lu%2CY&author=Zi%2CX&author=Zhao%2CY&author=Mascarenhas%2CD&author=Pollak%2CM?
- How much does https://doi.org/10.1016%2FS1535-6108%2804%2900050-9 make?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20the%20insulin-like%20growth%20factor%20receptor-1%20tyrosine%20kinase%20activity%20as%20a%20therapeutic%20strategy%20for%20multiple%20myeloma%2C%20other%20hematologic%20malignancies%2C%20and%20solid%20tumors&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2804%2900050-9&volume=5&pages=221-230&publication_year=2004&author=Mitsiades%2CCS&author=Mitsiades%2CNS&author=McMullan%2CCJ&author=Poulaki%2CV&author=Shringarpure%2CR&author=Akiyama%2CM
- What's the financial outcome of https://doi.org/10.1016%2Fj.ccr.2005.07.009?
- http://scholar.google.com/scholar_lookup?&title=The%20transcriptional%20repressor%20Snail%20promotes%20mammary%20tumor%20recurrence&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2005.07.009&volume=8&pages=197-209&publication_year=2005&author=Moody%2CSE&author=Perez%2CD&author=Pan%2CTC&author=Sarkisian%2CCJ&author=Portocarrero%2CCP&author=Sterner%2CCJ's financial summary
- Get to know what's the income of https://doi.org/10.1016%2FS1535-6108%2802%2900212-X
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Conditional%20activation%20of%20Neu%20in%20the%20mammary%20epithelium%20of%20transgenic%20mice%20results%20in%20reversible%20pulmonary%20metastasis&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2802%2900212-X&volume=2&pages=451-461&publication_year=2002&author=Moody%2CSE&author=Sarkisian%2CCJ&author=Hahn%2CKT&author=Gunther%2CEJ&author=Pickup%2CS&author=Dugan%2CKD?
- What's the profit of https://doi.org/10.1038%2Fsj.onc.1210379?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%3A%20triumphs%20and%20tribulations&journal=Oncogene&doi=10.1038%2Fsj.onc.1210379&volume=26&pages=3637-3643&publication_year=2007&author=Nahta%2CR&author=Esteva%2CFJ?
- How much income does https://doi.org/10.1016%2Fj.bcp.2007.10.032 have?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cytochrome%20P450%202A5%20in%20a%20glucose-6-phosphate%20dehydrogenase-deficient%20mouse%20model%20of%20oxidative%20stress&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2007.10.032&volume=75&pages=1230-1239&publication_year=2008&author=Nichols%2CKD&author=Kirby%2CGM make?
- What's the revenue for https://link.springer.com/doi/10.1007/BF01833331?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20IGF-I%20and%20IGF-II%20mRNA%20in%20breast%20tissue&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01833331&volume=22&pages=31-38&publication_year=1992&author=Paik%2CS?
- What are the earnings of https://doi.org/10.1038%2Fsj.bjc.6690112?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Altered%20expression%20of%20the%20IGF-1%20receptor%20in%20a%20tamoxifen-resistant%20human%20breast%20cancer%20cell%20line&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6690112&volume=79&pages=693-700&publication_year=1999&author=Parisot%2CJP&author=Hu%2CXF&author=DeLuise%2CM&author=Zalcberg%2CJR?
- How much money does https://doi.org/10.1093%2Fnar%2Fgkj155 generate?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=RTPrimerDB%3A%20the%20real-time%20PCR%20primer%20and%20probe%20database%2C%20major%20update%202006&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkj155&volume=34&pages=D684-D688&publication_year=2006&author=Pattyn%2CF&author=Robbrecht%2CP&author=De%2CPA&author=Speleman%2CF&author=Vandesompele%2CJ generate?
- https://doi.org/10.1038%2Fnrc2131 income
- How much does http://scholar.google.com/scholar_lookup?&title=Snail%2C%20Zeb%20and%20bHLH%20factors%20in%20tumour%20progression%3A%20an%20alliance%20against%20the%20epithelial%20phenotype%3F&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2131&volume=7&pages=415-428&publication_year=2007&author=Peinado%2CH&author=Olmeda%2CD&author=Cano%2CA pull in monthly?
- Income figures for https://doi.org/10.1073%2Fpnas.0801197105
- http://scholar.google.com/scholar_lookup?&title=Oncogene%20cooperation%20in%20tumor%20maintenance%20and%20tumor%20recurrence%20in%20mouse%20mammary%20tumors%20induced%20by%20Myc%20and%20mutant%20Kras&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0801197105&volume=105&pages=5242-5247&publication_year=2008&author=Podsypanina%2CK&author=Politi%2CK&author=Beverly%2CLJ&author=Varmus%2CHE's financial summary
- How much does https://doi.org/10.1038%2Fnrc1387 earn?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factors%20and%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1387&volume=4&pages=505-518&publication_year=2004&author=Pollak%2CMN&author=Schernhammer%2CES&author=Hankinson%2CSE?
- What's the monthly income of https://doi.org/10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C?
- How much does http://scholar.google.com/scholar_lookup?&title=Metastasizing%20mammary%20carcinomas%20in%20H19%20enhancers-Igf2%20transgenic%20mice&journal=J%20Exp%20Zool&doi=10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C&volume=281&pages=43-57&publication_year=1998&author=Pravtcheva%2CDD&author=Wise%2CTL generate monthly?
- How much money does https://doi.org/10.1016%2FS0140-6736%2804%2916044-3 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20%28IGF%29-I%2C%20IGF%20binding%20protein-3%2C%20and%20cancer%20risk%3A%20systematic%20review%20and%20meta-regression%20analysis&journal=Lancet&doi=10.1016%2FS0140-6736%2804%2916044-3&volume=363&pages=1346-1353&publication_year=2004&author=Renehan%2CAG&author=Zwahlen%2CM&author=Minder%2CC&author=O%E2%80%99Dwyer%2CST&author=Shalet%2CSM&author=Egger%2CM earn?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9515800?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Elevated%20insulin-like%20growth%20factor%20I%20receptor%20autophosphorylation%20and%20kinase%20activity%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=1159-1164&publication_year=1998&author=Resnik%2CJL&author=Reichart%2CDB&author=Huey%2CK&author=Webster%2CNJG&author=Seely%2CBL
- What are the total earnings of https://doi.org/10.1158%2F1078-0432.CCR-07-1109?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=IMC-A12%2C%20a%20human%20IgG1%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1109&volume=13&pages=5549s-5555s&publication_year=2007&author=Rowinsky%2CEK&author=Youssoufian%2CH&author=Tonra%2CJR&author=Solomon%2CP&author=Burtrum%2CD&author=Ludwig%2CDL
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7757999
- http://scholar.google.com/scholar_lookup?&title=Malignant%20breast%20epithelium%20selects%20for%20insulin-like%20growth%20factor%20II%20expression%20in%20breast%20stroma%3A%20evidence%20for%20paracrine%20function&journal=Cancer%20Res&volume=55&pages=2448-2454&publication_year=1995&author=Singer%2CC&author=Rasmussen%2CA&author=Smith%2CHS&author=Lippman%2CME&author=Lynch%2CHT&author=Cullen%2CKJ's total income per month
- How much does https://doi.org/10.1056%2FNEJM200103153441101 generate monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Use%20of%20chemotherapy%20plus%20a%20monoclonal%20antibody%20against%20HER2%20for%20metastatic%20breast%20cancer%20that%20overexpresses%20HER2&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200103153441101&volume=344&pages=783-792&publication_year=2001&author=Slamon%2CDJ&author=Leyland-Jones%2CB&author=Shak%2CS&author=Fuchs%2CH&author=Paton%2CV&author=Bajamonde%2CA?
- What's https://doi.org/10.1023%2FA%3A1009523501499's gross income?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Function%20of%20the%20IGF-I%20receptor%20in%20breast%20cancer&journal=J%20Mam%20Gland%20Biol%20Neoplasia&doi=10.1023%2FA%3A1009523501499&volume=5&pages=95-105&publication_year=2000&author=Surmacz%2CE make?
- What is the monthly revenue of https://doi.org/10.1016%2Fj.bbrc.2007.11.151?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Twist%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20gene%20expression%20in%20breast%20cancer&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2007.11.151&volume=367&pages=235-241&publication_year=2008&author=Vesuna%2CF&author=van%2CDP&author=Chen%2CJH&author=Raman%2CV?
- What is the earnings of https://doi.org/10.1016%2Fj.cell.2004.06.006?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Twist%2C%20a%20master%20regulator%20of%20morphogenesis%2C%20plays%20an%20essential%20role%20in%20tumor%20metastasis&journal=Cell&doi=10.1016%2Fj.cell.2004.06.006&volume=117&pages=927-939&publication_year=2004&author=Yang%2CJ&author=Mani%2CSA&author=Donaher%2CJL&author=Ramaswamy%2CS&author=Itzykson%2CRA&author=Come%2CC?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3180080 makes per month
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20II%20mRNA%20expression%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=48&pages=6691-6696&publication_year=1988&author=Yee%2CD&author=Cullen%2CKJ&author=Paik%2CS&author=Perdue%2CJF&author=Hampton%2CB&author=Schwartz%2CA?
- What are the total earnings of https://doi.org/10.1210%2Fmend-3-3-509?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20insulin-like%20growth%20factor%20I%20gene%20expression%20in%20malignancy%3A%20evidence%20for%20a%20paracrine%20role%20in%20human%20breast%20cancer&journal=Mol%20Endocrinol&doi=10.1210%2Fmend-3-3-509&volume=3&pages=509-517&publication_year=1989&author=Yee%2CD&author=Paik%2CS&author=Lebovic%2CGS&author=Marcus%2CRR&author=Favoni%2CRE&author=Cullen%2CKJ?
- How much does https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=references rake in every month?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Jones each month?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Jones%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20I%20Campbell?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20I%20Campbell%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20A%20Wood's revenue stream
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20A%20Wood%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20J%20Petrik's total income per month
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20J%20Petrik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Moorehead rake in every month?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Moorehead%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Reversibility%20and%20recurrence%20of%20IGF-IR-induced%20mammary%20tumors&author=R%20A%20Jones%20et%20al&contentID=10.1038%2Fonc.2009.79©right=Macmillan%20Publishers%20Limited&publication=0950-9232&publicationDate=2009-04-20&publisherName=SpringerNature&orderBeanReset=true gross monthly?
- How much profit does https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=citation make?
- How much income is https://doi.org/10.1038/s41388-018-0362-5 earning monthly?
- What are the total earnings of https://doi.org/10.1186/s12943-015-0291-7?
- What's https://doi.org/10.1038/onc.2013.373's gross income?
- What's the revenue for https://doi.org/10.1038/onc.2012.4?
- What is the earnings of https://doi.org/10.1007/s12282-011-0299-9?
- How much does https://www.protocols.io/ rake in every month?
- How much revenue does https://www.natureindex.com/ bring in?
- What's the monthly money flow for http://www.naturechina.com?
- Earnings of https://www.natureasia.com/ja-jp
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk